AdaptVac
Phase 3AdaptVac aims to development highly effective and long-lasting therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.
Founded
2015
Focus
Vaccines
About
AdaptVac aims to development highly effective and long-lasting therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.
Funding History
2Total raised: $25M
Series A$20MNovo HoldingsSep 15, 2020
Seed$5MNovo SeedsJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationCopenhagen, Denmark
StagePhase 3
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile